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Abstract 
A 76-year-old Japanese man was admitted to Kosei-Nenkin Hospital (Osaka, Japan) in 
November 2006; his chief complaint was a 10-kg loss in body weight over 3 months prior 
to admission. Abdominal computed tomography (CT) and dynamic magnetic resonance 
imaging (MRI) showed three masses in the retroperitoneum. The patient subsequently 
underwent surgery. The final histopathological diagnosis of tumors 1 and 2 was 
malignant fibrous histiocytoma of the retroperitoneum, and tumor 3 was a 
well-differentiated liposarcoma. By the presence of the liposarcoma, tumor 1 and 2 were 
thought to be the dedifferentiated areas of liposarcomas. At the age of 16, the patient 
had been exposed to radiation from the atomic bomb at Hiroshima towards the end of 
the Second World War. We postulate that in this case, radiation from the atomic bomb 
may have played an important role in the development of the sarcomas. 
 
Introduction 
Atomic bomb survivors are known to be at a high risk of developing various 
malignancies [1] containing sarcomas. We report a case of dedifferentiated liposarcoma 
in the retroperitoneum in an atomic bomb survivor.  
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Case Report 
A 76-year-old Japanese man was admitted to Kosei-Nenkin Hospital (Osaka, Japan) in November 
2006; his chief complaint was a 10-kg loss in body weight over 3 months prior to admission. He had 
undergone appendectomy at age 10 and percutaneous transluminal coronary angioplasty at age 70. At 
the age of 16, he had been exposed to radiation from the atomic bomb at Hiroshima towards the end of 
the Second World War. He did not have a family history of cancer. Physical examination showed a 
10-cm mass palpable on the right side of the abdomen, but no peripheral lymphadenopathy was 
observed. 
Serum white blood cell count and C-reactive protein were elevated to 9,200/μl and 4.94 mg/dl, 
respectively. Carcinoembryonic antigen, carbohydrate antigen 19-9, cancer antigen 125 and alpha-
fetoprotein showed no abnormalities. Abdominal computed tomography (CT) showed two 10-cm 
masses in the right side of the retroperitoneal space. Dynamic magnetic resonance imaging (MRI) 
showed two 10-cm masses (tumors 1 and 2) and another 5-cm mass (tumor 3) in the retroperitoneum 
(fig. 1). Tumor 1 at the inferior pole of the kidney appeared as a ring-enhanced mass in the late phase. 
Its posterior side was enhanced in the late phase. Tumor 3 was not enhanced. A T1-weighted image 
showed a low signal intensity in tumors 1 and 2 but a high intensity in tumor 3. A T2-weighted image 
showed a high intensity in tumors 2 and 3 and a slightly high intensity at the center of tumor 1. A 
positron emission tomography (PET) scan using fluorodeoxyglucose revealed slight uptake (SUVmax: 
early phase, 2.4; late phase, 2.8) at the border of tumor 1, and slight homogeneous uptake (SUVmax: early 
phase, 2.5; late phase, 2.2) in tumor 2, suggestive of liposarcoma. Tumor 3 was not detected by PET 
(fig. 2). We were unable to establish tumor diagnosis, but we ascertained that these tumors might be 
malignant. Brain MRI and chest CT showed no metastasis. 
The patient subsequently underwent surgery. We found that tumors 1 and 2 were present in the 
retroperitoneum, adjacent to the ascending colon. Tumor 3 was also present in the retroperitoneum and 
was located between the duodenum and the transverse mesocolon. The 3 tumors were resected with 
sufficient surgical margin. 
Macroscopically, the cut surface of tumor 1 (13 × 10 × 5 cm, weight 460 g) and tumor 2 (12 × 8 × 
6 cm, weight 460 g) was brown, glistening, and mucoid. That of tumor 3 (6 × 4 × 4 cm, weight 60 g) was 
yellowish (fig. 3). 
Microscopically, spindle fibroblast-like cells were arranged in a storiform pattern in tumors 1 and 2. 
Many mitotic figures and inflammatory cells were also found in these tumors (fig. 4a). 
Immunohistochemical staining yielded positive results for vimentin, α1-antichymotrypsin (fig. 4b), and 
Mib-1 (50%) (fig. 4c) and negative results for S-100, CD68, p53, and desmin. The final histopathological 
diagnosis of tumors 1 and 2 was malignant fibrous histiocytoma (MFH) of the retroperitoneum. Most 
parts of tumor 3 were composed of well-differentiated fat cells, which varied in size and shape, and a few 
lipoblasts were found, which had irregularly shaped nuclei and lipid droplets in their cytoplasm 
(fig. 4d). The final histopathological diagnosis of tumor 3 was well-differentiated liposarcoma. No 
residual tumor cells were observed on the resected surface of these 3 tumors. 
The patient had an uneventful postoperative course. He was not administered chemotherapy or 
radiation therapy because of his heart disease and was discharged on the 14th postoperative day. It is 
now 13 months after surgery, and the patient is doing well without any evidence of recurrence or 
metastasis. 
Discussion 
MFH was first described as malignant histiocytoma and fibrous xanthoma by Ozello et 
al. [2] in 1963, and it was reported as malignant fibrous xanthoma by O’Brien and Stout 
[3] of the same group in 1964. Weiss and Enzinger [4] pointed out that MFH was the 
most common sarcoma in adults, and the concept of MFH arose based on their study 
conducted in 1978. MFH is classified as a group of soft tissue sarcomas composed of both 
histiocytic and fibrous elements arranged in a storiform pattern and accompanied by 
pleomorphic giant cells, xanthoma cells, and inflammatory cells.  
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However, Coindre et al. [5] showed that in 17 of 25 cases in whom MFH in the 
retroperitoneum was initially diagnosed, dedifferentiated liposarcoma was the final 
diagnosis. Dedifferentiated liposarcomas have components of both well-differentiated 
liposarcoma and nonlipogenic sarcoma. They mainly occur in the retroperitoneal space, 
and the most common pattern in the dedifferentiated areas is that of high-grade 
pleomorphic MFH or storiform fibroblastic MFH [5]. Nowadays, many pathologists 
recognize that most so-called MFHs located in the retroperitoneum are dedifferentiated 
liposarcomas [6]. In our case, the immunohistochemical staining of tumors 1 and 2 
yielded positive results for vimentin and α1-antichymotrypsin, and the tumors were 
diagnosed as MFH. Tumor 3 was diagnosed as well-differentiated liposarcoma because 
most of it was composed of fatty tissue and few lipoblasts were observed. By the presence 
of the liposarcoma, tumors 1 and 2 were thought to be the dedifferentiated areas of 
liposarcomas. We finally diagnosed the present case as one of dedifferentiated 
liposarcoma in the retroperitoneum. Most area of tumor 3 was composed of adipocytes, 
which was the reason why tumor 3 was not detected in the preoperative PET scan. 
Several studies showed that radiation therapy increases the relative risk of subsequent 
sarcomas [6, 7]. Radiation-induced liposarcoma has been reported infrequently, but 
Orosz et al. [8] described the case of radiation-induced liposarcoma which showed 
dedifferentiation toward pleomorphic malignant fibrous histiocytoma. Atomic bomb 
survivors are known to have a high risk of developing various malignant and benign 
tumors [1]. A significantly high risk for cancers of the digestive system, breast, 
gastrointestinal tract, lung, skin, liver, ovary, urinary bladder, and other organs has been 
demonstrated in such persons [1]. The incidence of non-cancer diseases such as liver 
cirrhosis and myocardial infarction is also increased [9]. Preston et al. [10] demonstrated 
that the incidence of radiation-induced malignant tumors was 38% in atomic bomb 
survivors with irradiation doses ranging from 1 to 2 Sv, and it was 59% in survivors 
exposed to doses exceeding 2 Sv. Kamada et al. [11] reported that persons within 500 m 
from the hypocenter were exposed to irradiation doses ranging from 1.1 to 6.9 Sv. The 
present patient was exposed to radiation within 500 m from the hypocenter, and the 
irradiation dose was estimated to be more than 1.1 Sv. We postulate that in this case, 
radiation from the atomic bomb may have played an important role in the development 
of the sarcomas. 
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Fig. 1. MRI (T1-weighted image) showed the two 10-cm masses (tumors 1 and 2) (b) and another 5-cm 
mass (tumor 3) (a, c) in the retroperitoneum. A low signal intensity was detected in tumors 1 and 2, but 
a high intensity in tumor 3. 
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Fig. 2. A PET scan using fluorodeoxyglucose revealed slight uptake (SUVmax: early phase, 2.4; late 
phase, 2.8) at the border of tumor 1, and slight homogeneous uptake (SUVmax: early phase, 2.5; late 
phase, 2.2) in tumor 2, suggestive of liposarcoma. Tumor 3 was not detected by PET. 
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Fig. 3. The three tumors in the retroperitoneum were resected with sufficient surgical margin (a). 
Macroscopically, the cut surfaces of tumor 1 (13 × 10 × 5 cm in size, weight 460 g) (b) and tumor 2 
(12 × 8 × 6 cm, weight 460 g) (d) were brown, glistening, and mucoid. That of tumor 3 (6 × 4 × 4 cm, 
weight 60 g) (c) was yellowish. 
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Fig. 4. Microscopically, spindle fibroblast-like cells were arranged in a storiform pattern in tumors 1 
and 2 (a). Immunohistochemical staining yielded positive results for vimentin, α1-antichymotrypsin 
(b), and Mib-1 (50%) (c). Most parts of tumor 3 were composed of well-differentiated fat cells, and a 
few lipoblasts were found in tumor 3 (d). 
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